Skin & hair

Melanoma in Situ — Caught at the Very Start

Save

A diagnosis of melanoma in situ is frightening to read and, in an important sense, reassuring to understand. 'In situ' is Latin for 'in place' — the cancer has not moved. This explains what the diagnosis means, why it carries such a good prognosis, how it is removed, and what follow-up looks like once it is gone.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does melanoma in situ mean?

Melanoma in situ is melanoma caught at its very first stage, before it has done the thing that makes melanoma dangerous — invade. 'In situ' means 'in place': the abnormal pigment cells are still confined to the epidermis, the thin top layer of skin, and have not pushed down into the deeper dermis, where blood vessels and lymphatics could carry them elsewhere 1. In the staging system, this is stage 0, also written as Tis 2.

It is a genuine melanoma, not a false alarm — the cells are abnormal and would, if left, likely become invasive over time. But it is melanoma at the one moment when it has essentially no ability to spread. That combination — real cancer, caught before it can travel — is why the diagnosis reads as alarming and resolves as reassuring once it is understood.

Why 'In Situ' Is Such Good News

The reason melanoma in situ carries such a good outlook is mechanical: a cancer that has not reached blood vessels or lymphatics has no route to spread, so complete removal generally ends the story. Melanoma in situ has not invaded and essentially cannot metastasize, so it is usually cured by removing it. Its prognosis sits at the top of any melanoma survival rate by stage table.

For context on melanoma prognosis, melanoma found at the earliest, localized stage has a five-year relative survival of roughly 99 percent 3, and melanoma in situ is a step earlier still — the cancer has not even breached the layer it started in. The reassurance here is different from the reassurance this site refuses to give about an un-tested mole: it rests on a pathologist's reading of removed tissue, not on how a spot looks.

How Melanoma in Situ Is Diagnosed and Staged

Melanoma in situ is diagnosed by biopsy, and how the biopsy is taken matters. For a spot suspected of being melanoma, guidelines favor removing the whole lesion with a narrow margin — an excisional or deep saucerization biopsy — rather than a superficial shave or a partial sample, because the pathologist needs the full thickness to confirm the cells have not invaded and to measure depth accurately if they have 4. A partial sample can under-call the diagnosis.

Staging then places it in the melanoma stages framework. In the AJCC melanoma staging 8th edition, melanoma in situ is Tis and stage 0 — the category reserved for cancer that has not invaded 2. Because there is no depth to measure and no invasion, the extensive workup used for thicker melanomas is not needed here; the diagnosis and the stage come from the biopsy itself.

How Melanoma in Situ Is Treated

The standard treatment is surgical removal with a margin of normal-looking skin around the site, to clear any cells that extend beyond what the eye can see. For melanoma in situ, guidelines recommend a clinical margin of roughly half a centimeter to one centimeter, taken down through the full thickness of the skin 5. Once the edges are confirmed clear under the microscope, the melanoma is generally considered cured.

One subtype is handled differently. Lentigo maligna, a form of melanoma in situ that arises on chronically sun-damaged skin — often the face of older adults — has ill-defined borders that can extend past what is visible, so it is often treated with staged excision or Mohs surgery to confirm clear margins while sparing tissue 5. And because in situ disease has not invaded, the sentinel lymph node biopsy used to stage thicker melanomas is not part of the plan 1.

After the Diagnosis: Follow-Up and Lowering Future Risk

Once melanoma in situ is removed, the main task shifts from the treated spot to the rest of your skin. Having had one melanoma raises the risk of developing another, so regular skin checks with a dermatologist — and often a schedule of self-exams — become part of routine care. Much of what happens after melanoma diagnosis at this stage is surveillance rather than more treatment: watching for new or changing spots so the next one, if it comes, is also caught early.

Sun protection is the lever with the best evidence for lowering future risk. In a long-term randomized trial, adults who used sunscreen regularly developed fewer melanomas, including fewer invasive ones, than those who used it at their discretion 6. Combined with avoiding tanning beds and watching your own skin, that is the practical core of preventing a second melanoma after the first has been treated.

Catching the Next One Early

The habit that caught this melanoma is the same one that will catch the next: knowing your own skin and acting on change. Learning the melanoma warning signs — a spot that is asymmetric, has an irregular border, shows more than one color, is larger than a pencil eraser, or is changing — turns a vague worry into something specific to check. Knowing what early melanoma actually looks like helps too: it can be flat and subtle, not the dramatic dark lump people expect.

Melanoma in situ can arise anywhere, including places that get little sun. On the palms, soles, and under the nails, and in darker skin tones, it is sometimes found later — a pattern behind the concern about late melanoma diagnosis in skin of color — so those areas are worth including in any self-check. The through-line of this whole diagnosis is that early is everything, and you have already seen why: caught in place, melanoma is at its least dangerous.

Common questions

Yes. Melanoma in situ is a true melanoma — the cells are malignant. What sets it apart is timing: the cancer is still confined to the top layer of skin and has not invaded deeper tissue, so it has essentially no ability to spread. It is cancer caught at the one stage when complete removal is almost always curative, which is why the outlook is so good.

While it stays in situ, no. Spread requires reaching the blood vessels and lymphatic channels in the deeper dermis, and by definition melanoma in situ has not crossed into that layer. That is why it does not need sentinel lymph node biopsy or the workup used for thicker melanomas. The risk it carries is that, left untreated, it could eventually become invasive — which is why it is removed.

Recurrence at a properly excised site is uncommon once the margins are confirmed clear under the microscope. The larger concern is a new, separate melanoma elsewhere, because having had one melanoma raises the risk of another. That is why follow-up focuses on regular skin checks and watching for new or changing spots, rather than on the treated area alone.

Generally no. Because melanoma in situ has not invaded or spread, treatment is local removal of the lesion with a margin of normal skin. The sentinel lymph node biopsy, immunotherapy, and other treatments used for deeper or metastatic melanoma are not part of standard care for in situ disease. Surgery to clear the spot is usually the whole of the treatment.

Lentigo maligna is a subtype of melanoma in situ that develops on chronically sun-damaged skin, often the face of older adults, as a slowly enlarging flat brown patch. It is still in situ, so it shares the excellent prognosis. Its edges can be hard to see, so it is often treated with staged excision or Mohs surgery to confirm the margins are fully clear.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to check in after a melanoma-in-situ diagnosis

  • —A new or changing mole, or a spot that looks different from all your others, appearing anywhere on the skin after treatment
  • —A firm lump under the skin or a swollen lymph node near a previously treated melanoma site
  • —A treated excision site that develops a new bump, dark spot, or non-healing sore
  • —A dark streak under a nail, or a new dark patch on a palm or sole, whether or not it seems to be growing

This article explains what a melanoma-in-situ diagnosis means and how it is generally managed; it is not a substitute for the pathology report and plan from the clinician treating you. Staging, margins, and follow-up are decisions for that team, based on your specific results.

References

  1. 1.National Cancer Institute (PDQ Adult Treatment Editorial Board) (2025). Melanoma Treatment (PDQ®)–Health Professional Version. NIH / National Cancer Institute. link ✓Melanoma in situ consists of malignant melanocytes confined to the epidermis without invasion into the dermis; sentinel lymph node biopsy is used to stage thicker invasive melanomas, not in situ disease.
  2. 2.Gershenwald JE, Scolyer RA, Hess KR, et al. (2017). Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians. doi:10.3322/caac.21409In AJCC 8th edition staging, melanoma in situ is classified as Tis and stage 0 — the category for melanoma that has not invaded.
  3. 3.National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025). Cancer Stat Facts: Melanoma of the Skin. NIH / National Cancer Institute (SEER). linkFor melanoma of the skin diagnosed at a localized (early) stage, five-year relative survival is approximately 99 percent.
  4. 4.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. link ✓For a suspected melanoma, a narrow full-thickness excisional or saucerization biopsy is preferred over superficial shave or partial punch sampling to confirm the diagnosis and preserve staging accuracy.
  5. 5.Swetter SM, Tsao H, Bichakjian CK, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055Recommended surgical excision margins for melanoma in situ (about 0.5 to 1 cm), and staged excision or Mohs micrographic surgery for lentigo maligna.
  6. 6.Green AC, Williams GM, Logan V, Strutton GM (2011). Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. Journal of Clinical Oncology. PMID 21135266 ✓In long-term follow-up of a randomized trial, regular sunscreen use reduced the incidence of melanoma, including invasive melanoma, compared with discretionary use.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library